Identifying ALS subtypes, determining root cause(s), and developing targeted treatments for a future without ALS.
While the scientific community has made progress in ALS research, it faces formidable barriers, including insufficient funding, technology infrastructure, and data science expertise. These obstacles stifle the pace of discovery and innovation. But this is where the Vision 2030 AI Research Hub steps in to dismantle these barriers and chart a course toward unraveling ALS’s complexities.
At EverythingALS, our mantra of “care to cure” is encapsulated in our Vision 2030 plan. Our mission transcends the conventional non-profit model, adopting a dynamic, for-profit mindset focused on achieving a singular, transformative goal: the eradication of ALS by the year 2030. This target year is not just a deadline, but a milestone driven intention, marking the moment we aim to render our services obsolete in a world liberated from ALS.
People will have a neurodegenerative
disease by 2030
Neurodegenerative disorders are the second-highest cause of death globally
Every 90 minutes someone
is diagnosed with ALS
Eliminate or reduce neuronal, glial and axonal dysfunction
Repair or regenerate motor neurons, axons and glial
Promote and accelerate repair and regeneration
Return brain function and enhance quality of life
Restore nerve-muscle connection and communication
The pursuit of knowledge about the root causes and the intricate biological mechanisms leading to motor neuron loss in ALS, which we classify as “repair and regeneration research”, is desperately underfunded. To bridge this gap, we are embarking on a critical fundraising endeavor, aiming for an initial one hundred million dollars over the next year. This first round of funds will finance promising research to find a cure.
